Skip to main content
Markdown filings API. Get API access →
OICS v0.3.3 class · Healthcare

Clinical-Stage Biotech

ID CLB HC.PH.BIO.CLB

Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.

Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.

Sector
HC Healthcare in the standard Medicines, medical technology and the delivery of care.
Group
HC.PH Medicines & Life Sciences Developing and making medicines, and the tools and services for it.
Industry
HC.PH.BIO Biotechnology in the standard Biology-based drug developers.

Companies whose primary class this is. The sector and industry pages and the screener count them the same way.

Counted by primary class: companies that are listed and have filings on FinancialFilings.

Company Ticker Country Market cap Filings
CHITOGENX INC CHGX Canada — 366
Sirona Biochem Corp. SRBCF Canada — 366
Voronoi, Inc. 310210 South Korea — 366
PharmaLundensis AB PHAL Sweden — 362
MedPacto, Inc. 235980 South Korea — 360
Ensol Biosciences Inc. 140610 South Korea — 359
Quest PharmaTech Inc. QPT Canada — 359
Delta-Fly Pharma, Inc. 4598 Japan — 357
SinoMab BioScience Limited 3681 Hong Kong — 351
Biora Therapeutics, Inc. BIORQ United States of America — 347
Jacobio Pharmaceuticals Group Co., Ltd. 1167 Cayman Islands — 345
Geneuro GEM Switzerland — 342
Biocure Technology Inc. CURE.X Canada — 341
AION THERAPEUTIC INC. AION Canada — 336
Defence Therapeutics Inc. DTC Canada — 335
Kintor Pharmaceutical Limited 9939 Hong Kong — 333
VECTUS BIOSYSTEMS LIMITED VBS Australia — 333
Hookipa Pharma Inc HOOK United States of America — 331
Quratis Inc. 348080 South Korea — 326
PHARMARESEARCH BIO Co., Ltd. 217950 South Korea — 322
TMS Co., Ltd 4891 Japan — 322
Aptamer Sciences Inc 291650 South Korea — 319
Brii Biosciences Limited 2137 Cayman Islands — 319
FIREBRICK PHARMA LIMITED FRE Australia — 318
Rakovina Therapeutics Inc. RKV Canada — 317
CARsgen Therapeutics Holdings Limited 2171 Hong Kong — 314
Inventage Lab Inc. 389470 South Korea — 310
Respiratorius AB RESP Sweden — 309
FunPep Company Limited 4881 Japan — 303
Universal Ibogaine Inc. IBO Canada — 302
INVEX THERAPEUTICS LTD IXC Australia — 299
ARGENICA THERAPEUTICS LIMITED AGN Australia — 297
Wesana Health Holdings Inc. WESA.X Canada — 292
NeoImmuneTech, Inc. 950220 South Korea — 288
PharmaTher Holdings Ltd. PHRM Canada — 288
TWi Biotechnology, Inc 6610 Taiwan — 284
Affimed N.V. 0HL9 Netherlands — 278
AngioLab, Inc. 251280 South Korea — 278
Renascience Inc. 4889 Japan — 273
Awakn Life Sciences Corp. (1169082 BC Ltd.) AWKN Canada — 271
Tsubota Laboratory Incorporated 4890 Japan — 271
Nirvana Life Sciences Inc NIRV Canada — 270
Immunotech Biopharm Ltd 6978 Hong Kong — 266
Marvel Biosciences Corp. MRVL Canada — 266
curacle co., ltd. 365270 South Korea — 263
AP Biosciences Inc 6945 Taiwan — 261
DexTech Medical AB DEX Sweden — 259
Jiangsu Recbio Technology Co., Ltd. 2179 China — 258
Vaxil Bio Ltd. VXL Canada — 257
TaiwanJ Pharmaceuticals Co., Ltd. 6549 Taiwan — 256

Companies in Biotechnology → Open in the screener →

Other names for this activity, and where neighboring activities go instead.

Also known as

preclinicaldrug developer

Not here
Commercial Biotech CMB HC.PH.BIO.CMB

Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.

https://financialfilings.com/oics/CLB/

This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.

See it in the full standard Download the standard